Petry, Christopher,Gikanga, Benson,Chih, Hung-Wei,Liu, Jun
申请号：
AU2016344133
公开号：
AU2016344133A1
申请日:
2016.10.27
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Pharmaceutical formulations comprising monoclonal anti-Factor D antibodies, and their production and use for the treatment of complement-associated ocular diseases are disclosed. The formulations include pre-lyophilized, lyophilized and reconstituted stable liquid formulations of anti-Factor D antibodies, including lampalizumab.
